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Abstract. The sale of artemisinin-based combination therapy (ACT) by private licensed chemical shops (LCS) without
testing is contrary to current policy recommendations. This study assessed the accuracy and perception of test-based
management of malaria usingmalaria rapid diagnostic test (mRDT) kits at private LCS in two predominantly rural areas in
themiddle part ofGhana. Clients presenting at LCSwith fever or other signs and symptoms suspected to bemalaria in the
absenceof signsof severemalariawere testedwithmRDTby trainedattendants and treatedbasedon thenationalmalaria
treatment guidelines. Using structured questionnaires, exit interviews were conducted within 48 hours and a follow-up
interview on day 7 (±3 days). Focus group discussions and in-depth interviews were also conducted to assess stake-
holders’perception on the use ofmRDT at LCS. About 79.0% (N= 1,797) of clients reportedwith a fever. Sixty-six percent
(947/1,426) of febrile clients had a positive mRDT result. Eighty-six percent (815/947) of clients with uncomplicated
malaria were treated with the recommended ACT. About 97.8% (790/808) of clients with uncomplicated malaria treated
with ACTwere reported to bewell by day 7. However, referral for those with negativemRDT results was very low (4.1%,
27/662). A high proportion of clients with a positive mRDT result received the recommended malaria treatment. Test-
basedmanagement ofmalaria by LCS attendants was found to be feasible and acceptable by the communitymembers
and other stakeholders. Successful implementation will however require effective referral, supervision and quality
control systems.
INTRODUCTION
Innovative malaria case-management strategies are ur-
gently needed in sub-SaharanAfrica (SSA) if the global targets
of reducing the malaria incidence and mortality by at least
90% in 2030 are to be achieved.1 This is because access to
health services in SSA, the region with the heaviest disease
burden is inadequate and people travel long distances to seek
formal health-care services.2,3 As a result, private auxiliary
pharmaceutical outlets popularly known as licensed chemical
shops (LCS) fill this void by supplying by retail only, over-the-
counter medicines (Class C), including antimalarials in the
community.4
Licensed chemical shops are found in almost every town or
village in Ghana and are the first point of call when most
community members are unwell probably because of their
ease of access to services at relatively lower cost.5,6 They,
therefore, play a complementary role in the formal health
system by bringing health-care services to the doorsteps of
people in deprived communities.7
The Pharmacy Council of Ghana (PCG) oversees the reg-
istration, accreditation, and operations of LCS.4 Application
for a license is open to only adult Ghanaian citizens with a
minimum high school education. Before issuing a license, the
premises of an applicant are first inspected to assess ease of
access by customers and it is also ensured that facilities are
available for optimal storage of medicines. The approval for a
license is given when the minimum requirements are met and
is subject to renewal every year. Licensure is restrictive in
nature as the licensee can only operate from the approved
location specified on the license. Notwithstanding these
guidelines and regulations, infringements on the use of un-
authorized personnel and substandard premises have been
reported.8,9 In addition, poor prescribing practices such as
sales of prescription-only medications and polypharmacy are
common in the community.
The recommended treatments for uncomplicated malaria
are artemisinin-based combination therapy (ACT), namely,
artesunate–amodiaquine, artemether–lumefantrine, and
dihydroartemisinin–piperaquine.10 The treatment of sus-
pected malaria through the sale of ACT at LCS without any
confirmation of diagnosis is contrary to the World Health Or-
ganization’s policy recommendations to test and treat all
suspected cases of malaria regardless of age and malaria
transmission levels.11,12 The clinical and economic benefits in
averting inappropriate use of ACT have been evident in set-
tings where this policy is in practice.13–15 Currently, malaria
rapid diagnostic test (mRDT) kits are provided freeof charge to
most health facilities by the National Malaria Control Program
(NMCP) under a Global Fund program. At health facilities
registered as service providers under the National Health In-
suranceScheme (NHIS), the cost ofmRDT is covered forNHIS
subscribers.16 However, at private health facilities that do not
provide services on behalf of the insurance authority, the cost
of mRDT may be subsidized or paid for at market price
depending on the availability of mRDT supplies from the
NMCP.
It has been posited that empowering LCS to confirm the
presence of malaria with mRDT, especially in highly endemic
malaria regions, will improve access to ACT under rational
drug use and align practice with the current malaria man-
agement protocols.7,17
Test-basedmanagement ofmalaria (TbMM)usingmRDTby
trainednon-health professionals hasbeen found tobe feasible
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in Uganda, Senegal, and other African countries and recom-
mended for other high–malaria transmission areas of which
Ghana is included.18–20 The use of mRDT by non-health pro-
fessional is most appropriate, given their ease of use with
minimal training and logistical requirements.21,22
In this study, we assessed the proportion of clients sus-
pected of uncomplicated malaria and tested with mRDT who
received the recommended ACT at LCS in two predominantly
rural areas in the middle part of Ghana. In addition, the per-
ceptions of community members and stakeholders on the use
of mRDT at LCS for managing malaria were explored.
MATERIALS AND METHODS
Study site and design. The study was carried out in the
Kintampo North Municipality and Kintampo South districts
which lie within the forest savannah transitional ecological
zone in the Brong Ahafo region of Ghana. Both districts cover
an area of 7,162 km2 with a resident population of approxi-
mately 140,000.23 Farming is the main economic activity with
increasing level of petty trading. Malaria transmission is high
(269 infective bites per person per year) throughout the year,
with the highest intensity between May and October.24 The
incidence ofmalaria among children less than 5 years of age in
2003was about sevenmalaria episodes per child per year, but
recent evidence suggests much lower incidence.25 The study
area had 26 community-based health-planning services, 12
health centers/clinics, and two district/municipal hospitals
which serve as patient referral centers. In addition, there are
three pharmacy shops and 68 LCS.
The study design was mixed methods using a cross-
sectional survey, in-depth interviews (IDIs), and focus group
discussions (FGDs). The study was carried out between
March and October 2013.
Selection of LCS. All LCS in the study area were invited to
participate in the study. However, a shop was included in the
study if they met the following eligibility criteria: 1) the shop
was in good standing with the Pharmacy Council (who over-
sees the work of LCS), demonstrated by a valid current cer-
tification; 2) the shop attendant has basic literacy and
numeracy skills; and 3) the attendant operated from a recog-
nized shop open at least once a week. In all, shop attendants
from 42 LCS participated in the study.
Training and provision of logistics for LCS. A 1-week
training workshop was organized for all licensed chemical
shop attendants (LCSA) from LCS that met the study eligibility
criteria. The training was facilitated by the district health
management team using the PC training manuals and the
2009 Ghana NMCP malaria treatment guidelines.26 The
training package included malaria symptom recognition,
identification of general danger signs, and how to collect
finger-pricked blood samples for mRDT using sterile tech-
niques. The treatment of malaria based on proper in-
terpretation of mRDT results was explained. The LCSA were
further advised to withhold ACT treatment from a client if the
mRDT is negative and any of the signs and symptoms of se-
vere malaria were absent. Such persons were to be given
palliative treatment where necessary and counselled to return
for referral if their conditions persist or deteriorate in the next
24 hours. The need to refer immediately pregnant women,
children less than 6 months, and those presenting with any
danger signs to the nearest health facility and theprocesses to
followwere explained. In addition, the essence of good record
keeping was explained.
Study-specific inputs namely CareStart® mRDT kits (Ac-
cess Bio, Inc., Somerset, NJ), gloves, and safe disposal bins
were supplied by NMCP and distributed free of charge to
participating LCS. Logbooks for recording patient information
and treatment protocols were also supplied to each of the
shops. Licensed chemical shops were however required to
procure ACT through their normal procurement channels. The
NMCP malaria district focal persons in the districts sub-
sequently undertook bimonthly supervisory visits to the LCS
to ensure adherence to aseptic practices and offered support
on proper bookkeeping.
Trainingof thestudy team.A2-week trainingworkshopwas
organized for the study teamwho undertook the data collection.
Data collectors had aminimumof a high school certificate and at
least 3yearsof researchexperiencewhich is equivalent toGhana
Health Service (GHS) trainee technical officer. The team was
trained on the study objectives, data collection procedures, and
general field techniques. The team also received training on how
to administer the study questionnaire and correct techniques for
assessing the validity of mRDT results.
The training involved practical sessions and a pilot of the
study tools and procedures. Feedback on the suitability of
studyquestionnaireswasdiscussedandnecessary corrective
measures were addressed before the study commenced.
Sample size estimation. Accuracy of TbMM was defined
as the proportion of clients presenting at the LCSwith fever or
other malaria-suspected signs and symptoms in the absence
of signs of severe malaria who were tested with mRDT and on
the basis of a test result treated in linewith the nationalmalaria
treatment guidelines. In a recent study, the accuracy of TbMM
among health personnel was found to be 66.7%.27 Assuming
a power of 85% at the 95% confidence level and a 20%
clustering effect, a sample size of 1,680 clients presenting at
the LCS suspected of malaria was required. Accounting for a
5% nonresponse rate, a minimum of 1,764 clients was esti-
mated to determine the accuracy of TbMM by LCSA.
Quantitative surveys. Any client presenting with fever or
other malaria signs and symptoms in the absence of signs of
severe malaria was invited to participate in the study. Detailed
study information, including the objectives, design, and pro-
cedures, formalaria testing anddata collectionwere provided.
Clients or their caregivers were given the opportunity to ask
questions or mention any issue of concerns relating to the
study. All questions and clarifications were addressed before
a written consent was obtained. Two copies of the consent
formswere signed and a copy given to the study participant or
the caregiver. About 0.5 μL of finger-pricked blood was
obtained from each consented participant for mRDT by the
LCSA. The personal details of the clients, including household
and telephone contact numbers,mRDT results, and treatment
given, were recorded in a logbook. The mRDT results were
independently confirmed by a trained laboratory technician
within an hour after reading. Trained field staff obtained the
contact details of clients and followed them at their homes for
exit interviews within 48 hours of consultation. The choice of
clients’ home was to provide a convenient place for an in-
terview without any influence from the LCSA. A second home
visit was made on day 7 (±3 days) to ascertain patients’
treatment outcome. Using a structured questionnaire, in-
formation on clients’ demographics, presenting symptoms,
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and LCSA diagnoses and treatment were collected. Last, an
inventory of antimalarials, supporting medications, and other
logistics (functional weighing scales, thermometers, and ma-
terials for administering drugs) was conducted at the LCS.
Qualitative method. Each interview was performed by two
trained research officers with a basic degree in the social
sciences and a minimum 3 years of experience conducting
qualitative interviews.
Focus group discussion. Six FGDs were conducted sepa-
rately: three among clients/caregivers who had recently
sought care at LCS involved in the study and three among
caregivers of children aged less than 5 years (< 5) who never
accessed services at any LCS since the inception of the study.
Communities were purposively selected based on their ho-
mogeneities and geographical locations. Respondents for
thosewhoused the LCSwere randomly selected from the lists
of entries made in the logbooks. These selections of discus-
santswere restricted to the purposively selected communities
in which LCS were located. Caregivers of children aged < 5
yearswhonever accessedservices at anyLCS in the courseof
the study were randomly selected from the database of the
Kintampo Health and Demographic Surveillance System.23
Each FGD comprised 6–12 participants and lasted for about
an hour. The FGDs explored the perceptions of TbMM by the
LCSA using mRDT, affordability of malaria treatment, quality
of care, and other related issues.
In-depth interview. Fourteen IDIs were conducted among
key stakeholders. These include district health authorities,
health service providers, district health insurance managers,
community opinion leaders, and LCSA (Table 1). Licensed
chemical shop attendants were interviewed on their treatment
practices, experiences, and challenges encountered in the
management of clients using mRDTs. The perceptions of
these stakeholders on LCSA ability to undertake TbMM in the
community were also assessed.
Data management and analysis. Administered survey
questionnaires were manually checked for completeness and
consistency. Double data entry and validation were carried out
using Microsoft Access (Microsoft Corp 2013, Redmond, WA).
The quantitative analysis was carried out in STATA, version 12
(StataCorp, College Station, TX). Information on LCS, including
demographics of LCSA, was summarized into percentages.
Clientswere categorized into age groups anddata summarized
as frequencies and proportions with corresponding 95% con-
fidence interval adjusted for clustering per LCS.
Qualitative interviews were conducted in the local dialect
among community respondents and in English language
among health stakeholders. They were digitally recorded and
transcribed verbatim. Those in the local dialect were back-
translated to the English language within 24–72 hours after
each interview session. The audio recordings were in-
dependently vetted to ensure they matched with the tran-
scripts. Themes identified a priori from the study objectives
were as follows: use and acceptability of TbMM using mRDT,
referral of danger signs to health facilities, cost, and potential
challenges of TbMMusingmRDT.UsingNVivo version 8 (QSR
International, Australia), two independent researchers coded
the transcripts. To ensure inter-coder agreement, 10% of the
transcripts were coded independently. This was followed by
debriefing sessions to discuss and agree on common themes.
Inter-coder agreementwasmore than 90%.Emerging themes
were also derived from the data. Anonymized quotes that best
described these themes were included to support the quan-
titative findings.
Ethical consideration. Approvals were obtained from the
Kintampo Health Research Center (KHRC) Scientific Review
Committee and KHRC Institutional Ethics Committee, as well
as the Ghana Health Service Ethical Review Committee. An
informed written consent was obtained by a field staff from all
adult patients or caregivers of children less than 18 years old.
In addition, adolescents aged 12 to –17 years gave their
written assent. Unaccompanied minors were excluded from
the study. All study forms and digital data are kept under lock
and key, with restricted access.
RESULTS
Description of the study population. Forty-two of the 65
LCS that met the selection criteria were included in the study.
Altogether, 1,973 suspected malaria cases were tested with
mRDTs at the LCS. Eventually, matched datasets of exit in-
terviews and validated mRDT results of 1,797 clients were
analyzed. Seventy-six clients who could not be identified at
their addresses for the exit interviews were excluded. Fur-
thermore, 25 poorly labelled mRDT cassettes and 75 mRDT
results found to be inconclusive on independent verifica-
tion by trained laboratory technicians were also excluded
(Figure 1).
Background characteristics of LCSA and clients. The
mean age of LCSA was 44 years (standard deviation [SD]:
TABLE 1
Summary of respondents in the in-depth interviews
Category Role/description Number of interviews
Health stakeholders (n = 5)
District health management team Implementers of community health programs at
the district level
1
Hospital management team Clinical management of malaria 1
Laboratory technologists Laboratory diagnosis at the district hospital. 1
National Health Insurance Authority,
district management
Stakeholder in health financing 2
Community members (n = 3)
Opinion leaders Key informant in the community 3
LCSA in the study (n = 6)
LCSA Located in rural communities 3
LCSA Located in urban communities 3
Total 14
LCSA = licensed chemical shop attendant.
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11.5). Majority (90.5%) of the shop attendants were males
(Table 2). Sixty-nine percent of shop attendants had at least a
high school education (Table 2).
About 20.3% of clients presenting at LCS were children
aged < 5 years (Table 2). Fifty-seven percent of the clients
were males (Table 2). The reported use of insecticide treated
nets the night before the exit survey was 53.8% (Table 2). The
mean walking/travel time of clients visiting the LCS from their
homes was 14 (SD: 17.3) minutes.
The age range of focus group discussants in the quali-
tative interview was between 21 and 75 years; those be-
tween the ages of 31 and 40 years were in the majority
(Table 3). Females were slightly more than males. Farming
was the main occupation of the majority of discus-
sants (Table 3). The respondents in the IDIs were mainly
men (85.7%).
Presentations of complaints and use of antimalarials
before visiting LCS. The commonest presenting complaint
was fever (79.4%) (Table 4). The reported use of antimalarials
before the LCS visit for the current illness was low (2.8%,
52/1,797). These were leftover medications from previous
treatments or fromclose relatives and friends. About two-thirds
of antimalarials used were ACTs (65.4%, 34/52), mono-
therapies (13.5%, 7/52), and quinine (1.9%, 1/52); however,
19.2% (10/52) of clients did not know the type of antimalarial
used.
Licensed chemical shop attendants assessment of cli-
ents’ vitals and danger signs. The assessment of age and
fever was frequently performed among all age groups
(Figure 2).Weightwas infrequently (< 5%)measuredamongall
the age groups before drug administration. Clients were rarely
assessed for danger signs such as breathing or feeding
difficulty.
Accuracy of TbMMat LCS.A history of fever was reported
in 79.4% (1,426/1,797) of all clients, higher among children
aged < 5 years than in older clients (97.8% versus 74.7%;
P < 0.001) (Figure 3). Thosewith fever who had positivemRDT
results were 66.5% (Figure 3). This was significantly higher
among children aged < 5 years than in older clients (82.6%
versus 61.1%, P < 0.001). A positive malaria test was ob-
served among 35.8% (133/371) of clients who presented
without signs or symptoms of fever.
FIGURE 1. Description of the sample population and study procedure among clients visiting licensed chemical shops. LCS = licensed chemical
shops; LCSA = licensed chemical shop attendant; mRDT = malaria rapid diagnostic test; PCG = Pharmacy Council of Ghana.
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The accuracy of uncomplicated malaria (fever and mRDT
positive results) treatment with ACT among all clients was
86.1%(816/948); childrenaged<5yearswere83.4%(246/295)
and older participants, 87.3% (570/653) (Figure 3).
Artemisinin-basedcombination therapieswerewithheld in a
high proportion of clientswhowere suspected to havemalaria
but had a negative malaria test; this was 69.4% among clients
who presented with fever and 82.4% in those without fever
(Figure 3).
Outcome of treatment at LCS. The majority of clients
(97.4%, 1,639/1,682) who were either treated or counselled
reported being well on the follow-up visit. High recovery rates
were also reported among clients with uncomplicatedmalaria
(fever plusmRDTpositive results) givenanACTof 97.8% (790/
808). This was similar in children aged < 5 years (97.9%; 553/
565) and the older age group (97.5%; 237/243).
Referral of clients.Clients with a negativemRDT test in the
absence of any danger signs who were prescribed no medi-
cations but counselled to return for referral should their con-
ditionsworsenedwere only few (7.5%; 54/716). Referral to the
nearest health facility for clients with a negative mRDT result
was low (4.1%, 27/662). Of those referred, 81.5% (22/27)
adhered to the referral advice, but only seven (25.9%) did so
within 24 hours.
Perception on referral-related issues. The common condi-
tions that community members described as needing referral
to the health facilities were severe conditions such as jaun-
dice, hypertension, and human immunodeficiency virus/ac-
quired immune deficiency syndrome (HIV/AIDS).
“Jaundice is what worries me so if I go to the LCS and the
operator asks me to go the facility I have to go because
when I buy medicine at home to treat the sickness it
doesn’t help me. . . .” (IDI, opinion leader from rural Com-
munity B).
However, some health staff expressed concerns that LCS
are likely to delay referrals to sell their drugs. This concern is
expressed in the following quote:
“I think they are generating income so if you tell them to
refer those negativemalaria cases to the health facilities, it
means that they are increasing the income rate at the fa-
cility. They will prefer to treat the patients at their end
rather than refer. . . .” (IDI, laboratory technologist at Dis-
trict Hospital).
However, an LCSA attributed his low referral practices to
clients’ refusal to honor referral advice. According to him,
clients under the guise of obtaining first aid often failed to
report to the facility for further management.
“When a person has high body temperature, there is no
need keeping such a person at the drug store but some-
times, the relatives put pressure on you to give some initial
drugs which may not be effective.” (IDI, LCSA 4 from the
rural community).
In spite of the challenges of the low referral and referral
completion rates, a senior district health officer opined that an
optimized referral systemwas feasible if the capacity of LCS is
strengthened through effective education. Following is a de-
monstrative quote:
“Ifwehave regular contactswith them[LCS]andwekeepon
stressing that if you do the test and the result is negative the
condition may be due to several serious conditions so refer
quickly, they will but that will depend on the proximity from
their facility.” (IDI, district health management member).
Willingness to undergo rapid diagnostic testing for malaria.
Most community members indicated LCS as their first con-
venient point of call for the treatment of many ailments in the
TABLE 3
Background characteristics of focus group discussants
Characteristics
n (%)
All discussantsUsed LCS Did not use LCS
Gender
Male 17 (50.0) 10 (35.7) 27 (43.5)
Female 17 (50.0) 18 (64.3) 35 (56.5)
Age (years)
Range 21–75 23–65 21–75
Mean 37.8 35.8 36.9
Occupation
Farming 18 (52.9) 24 (85.7) 42 (67.7)
Trader 8 (23.5) 1 (3.6) 9 (14.5)
Student 3 (12.5) 1 (3.6) 4 (6.5)
Unemployed 3 (12.5) 0 3 (4.8)
Others 2 (5.9) 2 (7.2) 4 (6.5)
LCS = licensed chemical shops.
TABLE 4
Proportion of presenting symptoms/complaints among different age
groups at the first visit to licensed chemical shops
Numbers (n)
Age groups (years) All ages
< 5 5–10 11–19 20+ N %
365 267 225 940 1,797 100.0
Symptoms % % % % % %
Fever 97.8 98.5 83.6 65.7 1,426 79.4
Headache* – 53.6 76.4 72.8 999 69.8
Weakness 16.4 29.2 41.8 55.5 754 42.0
Chills* – 36.7 40.9 37.6 543 37.9
Shivering 16.2 24.3 10.2 11.9 259 14.4
Vomiting 52.9 52.1 23.6 12.9 506 28.2
Diarrhea 39.2 16.9 12.9 7.7 289 16.1
Cough 34.3 23.2 13.3 13.7 346 19.3
Nausea* – 7.1 19.6 14.8 202 14.1
Abdominal pains* – 31.8 32.4 20.2 348 24.3
* Not assessed among children aged < 5 years.
TABLE 2
Backgroundcharacteristics of licensedchemical shopattendants and
their clients
Background characteristics Frequency (n) Percent (%)
Licensed chemical seller (N = 42)
Male 39 90.5
At least high school education
(O’L/SSS/SHS)
29 69.0
Clients (N = 1,797)
Children < 5 year 365 20.3
Male 1,024 57.0
Holders of valid NHIS card 994 55.3
Slept under ITN the previous night 966 53.8
Household heads with minimum
high school education
317 17.6
ITN = insecticide treated net; NHIS = National Health Insurance Scheme; O’L = ordinary
level; SHS = senior high school; SSS = senior secondary school.
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community and that they only proceed to a health facility if
they do not get well after receiving the initial treatment.
“Wefirst go to thedrug store tobuy thedrugsbutwhenwe
see that there is no improvement then we go to the hos-
pital to seek for further treatment.” (Discussant 8, FGD
with users of LCS at Community E).
A community member who had not accessed services at
any of the participating LCS indicated her willingness to visit
the drug store if they have the capacity to conduct laboratory
investigations.
“If they have themalaria test at the drug store, thenwecan
visit there for the test because itmayhappen that the clinic
does not even have the drugs so we still have to come
back to the drug store to buy the malaria drug.” (Discus-
sant 1, FGD with nonusers of LCS at Community A).
Generally, respondents welcome TbMM using mRDT at
LCS. Thiswas reported tobeespecially good for thosewhodo
not have the means to visit the health facilities.
“If the test (mRDT) is brought to the LCS, it will be very
good especially for those of us in the village who cannot
afford to always visit the clinic or the hospital due to
transportation problems.” (Discussant 3, FGD with users
of LCS at Community B).
However, many caregivers of children aged less than 5
years said they visit thehealth centerwhen their child has fever
and proceed to the hospital if the condition persists.
“As for me if I will visit the health centre and if the illness
persist I proceed to hospital any time my child has a
fever.” (Discussant 1, FGD with nonusers of LCS at
Community A).
Rapid diagnostic testing as a means of improving malaria
diagnosis at LCS. Respondents also expressed the need
for testing (with mRDT) at the LCS as effective means of
improving malaria diagnosis before an ACT is prescribed.
The use of mRDT was perceived to boost the business
of LCS.
“I think it is good they take blood sample [for a test] to be
able to know whether the sickness is malaria or not, if the
test is done, you can be sure if it is malaria or not and the
right medicine will be given to you for treatment.” (IDI,
opinion leader from the urban community).
“Most patients like the mRDT test because they have re-
alized that it is the best way to diagnose malaria ... we, the
drug sellers want customers so if we get to use mRDTs, it
will pull customers for us. . . .” (IDI, LCSA 1 from the urban
community).
“I think it is a good thing for all of us because the rate at we
give out the malaria drugs will reduce. If you test and it is
not malaria you will not give the malaria drugs to them
[clients]. So it will be a very good thing.” (IDI, LCSA 4 from
the rural community).
There were, however, concerns whether the knowledge of
LCSA on the mechanisms under which mRDT works is ade-
quate, a situation that could results in misdiagnoses. This is
illustrated in the following quote:
“You see if they [LCSA] do not have knowledge on the
principle by which RDT works, they might misdiagnose.
. . . . a person suffering from other diseases but had
treatment for a recent malaria infection could still test
positive. If the operator doesn’t know all these, he might
give malaria drugs again but the patient may have other
serious conditions.” (IDI, laboratory technologist at Dis-
trict Hospital).
Another concern was whether LCSA will adopt aseptic
measures when drawing blood for a test, a practice that could
FIGURE 2. An assessment of vital and danger signs among clients at licensed chemical shops. This figure appears in color at www.ajtmh.org.
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exposeshopattendants andother clients to infections suchas
HIV and hepatitis. These are illustrated in the following
quotations:
“I think essentially it boils down to they [LCSA] being
able to employ aseptic techniques. Once you do any
form of puncture and body fluids are involved, the dis-
posal of these sharp objects if not done properly may be
a problem. They are at risk themselves getting infected
with any of the virus, i.e. hepatitis and HIV and could
infect other patients. Furthermore, many clinicians are
vaccinated against these viral infections but we might
not be able to say so for the LCSA.” (IDI, hospital
management member).
However, a community member who had visited an LCS
confirmed that aseptic techniques were employed when a
blood sample was taken for the malaria test.
“He put on gloves and used some medicine to clean my
fingertips before pricking me for the blood sample.” (IDI,
opinion leader from rural Community A).
FIGURE 3. Prescription of artemisinin-based combination therapy (ACT) by licensed chemical shop attendants based on the interpretation of
malaria rapid diagnostic test (mRDT) results amongclients suspectedwithmalaria. aClients suspectedwithmalaria; bclients suspectedwithmalaria
based on a presentation of fever; cclients suspected with malaria based on a presentation of other symptoms other than fever.
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Perceptions on cost of mRDT and LCS accreditation as
NHIS service providers. The cost of mRDT was seen as a
potential barrier to TbMM at LCS. Many expressed the desire
for the mRDT to be provided free of charge as pertains at the
health facilities or subsidized by government. This is because
customers will have to pay not only for the mRDT but also for
the medication that will be provided. This view is represented
in the following quotes:
“In fact, paying for both the test and drugs will even drive
us away from the drug stores to the hospital since when
one is insured he go to the hospital for free.” (Discussant
5, FGD with users of LCS at Community F).
“The only problem will be the money that you will have to
collect from the person, all the sick personswill like to test
but the only problem will be the money to pay for the test
and buy medications after the test.” (IDI, LCSA 6 from the
rural community).
Others,mainly subscribers of theNHISwould rather visit the
health facility if LCS will charge for the malaria test.
“I have made my mind that I will use my money for in-
surance so if the LCSwill charge formalaria test, then I will
rather visit the clinic instead.” (Discussant 6, FGD with
nonusers of LCS at Community D).
Licensed chemical shop attendants were willing to be
accredited as service providers for the NHIS. They were,
however, challenged by operational issues such as accredi-
tation requirements, perception of inadequate staffing, and
delays in NHIS reimbursement. These challenges had been
experienced by LCS operators.
“I am ready for accreditation any time becausewewant to
help in promoting health care and also it helps to getmore
customers. Some of the patients don’t have enough
money so if you have the accreditation they will use the
insurance to buy drugs from our end.” (IDI, LCSA 1 from
the urban community).
“Most of them do not want to register as a company so
that is the main problem. Some [LCS] do not have the
requisite staff, you go there and the one operating the
shop has not even completed senior high school to be
able to read prescriptions. Proper record keeping is also a
problem.” (IDI, NHIS district management member).
Perception on supply of mRDTs and antimalarials. The un-
interrupted supply and potential stock-out of mRDT and an-
timalarials were concerns expressed by LCSA in both the rural
and urban communities.
“One other challenge might be the continuous supply of
the RDT. If there is no shortage and we get continuous
supply, selling them will not be a problem.” (IDI, LCSA 5
from the rural community).
“We don’t actually get supply daily and more frequently
because some suppliers come even after one month of
supply so we always have to wait between these periods.
Assuming that I am supplied one box of malaria drugs
today and it get finished today, I still have to wait for the
next supply period to be able to re-stock and that is the
challenge.” (IDI, LCSA 3 from the urban community).
Functional thermometers were available at most shops
(Table 5). The availability of weight measuring scales was fairly
low for both infants andadults. Every shophadat least anACT in
stock during the study period (Table 5). More than 85.0% of the
shops had guides (posters, leaflets, etc.) for antimalarial treat-
ment available (Table 5). Water and cups were available in most
shops (66.7%) to immediately start drug administration (Table 5).
DISCUSSION
The accuracy and perception of TbMM usingmRDT at LCS
were assessed in this study. The majority (86.1%) of clients
with uncomplicated malaria received the recommended ACT
in accordance with the 2014 Ghana National Malaria Treat-
ment Guidelines. Contrary to the perception that LCSA are
likely to ignore negative mRDT results and inadvertently pre-
scribe antimalarials in the pursuit of their business interest,
ACT was withheld in a high proportion of clients who had a
negative malaria test. For example, 69.4% of febrile clients
with a negative malaria test and 82.4% of clients with other
symptoms initially suspected tobemalariawereprescribedno
antimalarials. Test-basedmanagement of malaria at LCS was
widely accepted as effective means of improving malaria di-
agnosis and treatment albeit few implementation challenges.
Our findings add to the growing evidence in many resource-
constraint countries, including Uganda,18 Ethiopia,19
Senegal,20,28 Sudan,29 Zambia,30 and Cambodia,31 that the
deployment of TbMM using mRDT by non-health profes-
sionals has proven to be an innovative strategy in improving
the specificity of malaria diagnosis and treatment.
Despite the high level of appropriate treatment for un-
complicated malaria, overtreatment (ACT prescription in the
absence of malaria parasitemia) was relatively high among
clients presenting with fever (30.6%) and those with other
symptoms (17.2%) initially suspected to be malaria. Such
poor prescribing practices are similar to findings from studies
even among health professionals.32,33 Notwithstanding sig-
nificant progress over the last decade in malaria case man-
agement, inappropriate treatment remains a challenge for
health systems of many malaria-endemic countries. The risk
of untreated malaria manifesting into severe malaria, particu-
larly for children, could be potentially fatal.34,35 Overexposure
to ACT, on the other hand, leads to build up in the overall drug
TABLE 5
The availability of ACT and other logistics at licensed chemical shops
at the start of the study
Characteristics Frequency Percent (%)
Had a functioning thermometer 29 69.0
Had a functioning infant weighing scale 6 14.3
Had a functioning adult weighing scale 8 19.0
Dosing cups and portable water available 28 66.7
Malaria treatment algorithms/guidelines/
flowchart
36 85.7
Had at least an ACT in stock 42 100.0
Had artesunate–amodiaquine 30 71.4
Had artemether–lumefantrine 29 69.0
Had dihydroartemisinin–piperaquine 12 28.6
ACT = artemisinin-based combination therapy. N = 42.
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pressure, facilitating the development of resistant strains of
the malaria parasite and rendering ACT inactive.36 Improving
access to antimalarials through the use of mRDT by trained
LCSA in the community poses a lesser threat to fostering re-
sistance to ACT than the current practice of presumptive
malaria treatment.37,38 The identification of artemisinin re-
sistance in five countries in the Greater Mekong subregion
must be a clarion call for malaria programmanagers to pursue
far-reaching interventions that mitigate against the develop-
ment of antimalarial resistance andprolong the therapeutic life
span of ACT.39,40
Another important observation in our study was that LCSA
rarely referred clients with negative malaria test (4.1%) and
only few referrals (25.9%)were honoredwithin 24 hours. Such
poor referral practices are major concerns that need to be
addressed. Factors identified as potential barriers to referral
include cost of transport, long waiting time at higher facilities,
severity of ailments, and perceived lack of competence at the
referred facility to properly manage cases.41,42 These factors
may have contributed to the low client referral completion al-
beit indirectly. The suspicion of malaria as the focus of clinical
investigation and the subsequent negative test for malaria are
likely to be perceived by community members as the absence
of any severe condition for which further management at
health facility may not be required.33 The clients’ persistent
failure tohonor referral advice after receiving first aid treatment
may perhaps account for the poor attitude of LCSA to refer, as
observed in a study in Sierra Leone.43 This may have lent
credence to the widely held perception mostly by health
workers that LCSA will rather pursue their business interest at
the expense of quality care for their clients. Similar findings
havebeenobserved in aUgandan study,where the reluctance
of accredited drug dispensers to refer clients due to previous
experience of not complying with referral advice after re-
ceiving first aid treatment was similarly misconstrued.18
Regular capacity-building programs for LCSA with the active
support of health workers will improve the conduct of LCSA
professionally and address these health worker mistrust.
The availability of simple functioning instruments (i.e. ther-
mometers and weighing scales) and the ability of LCSA to
accurately use them are important for proper management of
malaria. For example, most shops lack weighing scales and
could, therefore, not measure clients’ weight to calculate
correct doses required for treatment. Although dose estima-
tions based on weight are more reliable, the use of age band
indicators in the drug inserts or national treatment guidelines
as references for determining doses is an acceptable practical
alternative for less qualified LCSA that could avert errors in
calculating doses based on body weights.44,45
Our data suggest that the combined cost of mRDT and ACT
is a potential barrier to many people especially the rural folks.
The governmentmust ensure continuous provision of subsidy
on mRDT to make the cost of malaria treatment affordable to
rural dwellers. Furthermore, steps should be taken to make
LCS attractive points of care by accrediting them as service
providers under the NHIS. These initiatives are likely to ad-
dress the high indirect cost of malaria such as cost of travel;
and improve access toTbMMparticularly for rural dwellers.6 In
addition, innovative financingmechanismshould be explored.
For instance, Hansen et al. proposed the sale of mRDT and
ACTasasingle commodity,where acustomerwhopurchased
mRDT will be offered a course of ACT free or at a discounted
price if themalaria test is positive.46 Further research toassess
its feasibility and cost-effectiveness in our local context are
needed.
The ubiquity and convenience of access to LCS coupled
with inadequate health workforce have created the need for
alternate ways of addressing the health-care needs of people
living in communities underserved by the formal health sys-
tem. Licensed chemical shops can fill this void by taking
up easy-to-perform tasks traditionally reserved for skilled
health personnel to increase access to and uptake of health
services.18–20 In Ghana, the sale of depot medroxyprogester-
one acetate, a prescription-only injectable contraceptive to
women of reproductive age, and referral to qualified health
providers by LCS have been shown to be successful in in-
creasing access to safe family planning services.47 Identifying
the level of training needed to adequately equip LCS to provide
the required quality of care is key. Changes to existing health
legislations to allow and regulate LCS to delivering on their new
mandate are also needed.48
In light of our findings, a nationwide deployment of TbMMat
LCS requires the following efforts to ensure successful
implementation. First and foremost, LCSA need to be properly
trained to reorient their behavior to safe and acceptable
standardsof practice. For example, LCSAmust beable to take
a good history to identify danger signs and refer clients for
early and proper management at the health facilities. Second,
the PC needs to intensify efforts with the district malaria focal
persons to provide regular supportive supervision for strict
adherence to the licensed chemical sellers’ code of practice.
This will require the implementation of effective measures to
ensure that newly licensed shops are adequately trained on
the use and interpretation of mRDT results to achieve the high
level of accuracy observed in this study. Third, effective
community sensitization on improved LCS capability should
be aggressively pursued to engender community trust and
confidence in the operations of LCS and thereby promote
demand formalaria testing.49 Last, the availability and supply
of essential commodities, such as mRDT, ACT, gloves, and
other inputs, need to be sustained. The health system chal-
lenge of perennial shortages of mRDT and other commodi-
ties needs to be fixed.50–52 Government- or donor-supported
interventions aimed at addressing similar challenges often
involve free supply of such commodities. Such interventions
are difficult to sustain in themidst of competing health needs and
are stoppedwhen fundsaredepleted.53 Theprivate sector canbe
incentivized through the provision of tax exemptions to support
the importation and marketing of mRDT kits.54
In conclusion, the use of mRDT by LCSA is largely accu-
rate and acceptable to community members. However, po-
tential challenges associated with large-scale deployment
need to be addressed. These include continuous training
and supervision by the PCG in partnership with the local
health authorities to strengthen the capacity of LCS and
address the perceived weak regulatory oversight. Community
sensitizations aimed at addressing the poor referral practices
must also be pursued. In addition, quality control systems de-
rived from effective monitoring and evaluation regime must be
put in place.
Received December 12, 2017. Accepted for publication September
21, 2018.
Published online January 14, 2019.
272 KWARTENG AND OTHERS
Acknowledgments: We are grateful to the participants, community
opinion leaders, and all members of the Kintampo Licensed Chemical
Sellers’ Association for their support and cooperation; the Kintampo
HealthResearchCenter Institutional EthicsCommittee and theGhana
Health Service Ethical Review Committee for critically reviewing the
study protocols for approval; and the Global Fund who funded this
study through the Ghana National Malaria Control Program, Ghana
Health Service. Special thanks go to the Pharmacy Council of Ghana,
the Ghana National Malaria Control Program, and the management
and staff of Kintampo Health Research Center for their unflinching
support.
Financial support: The study was funded by the Global Fund through
the Ghana National Malaria Control Program of the Ghana Health
Service.
Authors’ addresses: Anthony Kwarteng, Lawrence Gyabaa Febir,
Theresa Tawiah, George Adjei, SolomonNyame, Francis Agbokey,Mieks
Twumasi, Seeba Amenga-Etego, and Kwaku Poku Asante, Kintampo
HealthResearchCenter (KHRC),GhanaHealthService,Kintampo,Ghana,
E-mails: anthony.kwarteng@kintampo-hrc.org, lawrence.febir@
kintampo-hrc.org, theresa.tawiah@kintampo-hrc.org, george.
adjei@kintampo-hrc.org, solomon.nyame@kintampo-hrc.org, francis.
agbokey@kintampo-hrc.org, mieks.twumasi@kintampo-hrc.org, seeba.
ae@kintampo-hrc.org, and kwakupoku.asante@kintampo-hrc.org.
Keziah L. Malm and Constance Bart-Plange, The National Malaria
ControlProgram,GhanaHealthService,Accra,Ghana,E-mails: keziah.
malm@ghsmail.org and constance.bartplange@ghsmail.org. Daniel
Amaning Danquah, The Pharmacy Council of Ghana, Ministry of
Health, Accra, Ghana, E-mail: dandanquah45@gmail.com. Seth
Owusu-Agyei, Institute of HealthResearch, University ofHealth and
Allied Sciences, Ho, Ghana, E-mail: sowusuagyei@uhas.edu.gh.
REFERENCES
1. World Health Organization, 2016. World Malaria Report 2016.
Geneva, Switzerland: WHO. Available at: http://www.who.int/
malaria/publications/world-malaria-report-2016/report/en/.
Accessed February 4, 2017.
2. Schellenberg JA, Victora CG,Mushi A, de SavignyD, Schellenberg
D, Mshinda H, Bryce J; Tanzania Integrated Management of
Childhood Illness MCE Baseline Household Survey Study
Group, 2003. Inequities among the very poor: health care for
children in rural southern Tanzania. Lancet 361: 561–566.
3. Sulemana A, Dinye RD, 2014. Access to healthcare in rural com-
munities inGhana: a studyof someselected communities in the
Pru district. Eur J Res Soc Sci 2: 122–132.
4. Ministry of Health, 2013. Health Professions Regulatory Bodies
Act, 2013. (Act 857). Accra, Ghana: Government of Ghana.
5. AsanteKPetal., 2010.Communityperceptionsofmalariaandmalaria
treatment behaviour in a rural district of Ghana: implications for
artemisinin combination therapy. BMC Public Health 10: 409.
6. Tawiah T, Asante KP, Dwommoh RA, Kwarteng A, Gyaase S,
Mahama E, Abokyi L, Amenga-Etego S, Hansen K, Akweongo
P, 2016. Economic costs of fever to households in the middle
belt of Ghana.Malar J 15: 68.
7. Alba S, Hetzel MW, Goodman C, Dillip A, Liana J, Mshinda H,
LengelerC, 2010. Improvements in access tomalaria treatment
in Tanzania after switch to artemisinin combination therapy and
the introduction of accredited drug dispensing outlets-a pro-
vider perspective.Malar J 9: 164.
8. Wafula FN, Miriti EM, Goodman CA, 2012. Examining character-
istics, knowledge and regulatory practices of specialized drug
shops in Sub-Saharan Africa: a systematic review of the liter-
ature. BMC Health Serv Res 12: 223.
9. Lowe RF, Montagu D, 2009. Legislation, regulation, and consol-
idation in the retail pharmacy sector in low-income countries.
South Med Rev 2: 35–44.
10. Ministry of Health, 2014. Guidelines for Case Management of
Malaria in Ghana, 3rd edition. Accra, Ghana: Ministry of Health.
11. World Health Organization, 2009. Parasitological Confirmation of
Malaria Diagnosis. Report of Technical Consultation. Geneva,
Switzerland: WHO. Available at: http://whqlibdoc.who.int/
publications/2010/9789241599412_eng.pdf. Accessed Feb-
ruary 14, 2017.
12. World Health Organization, 2015. Guidelines for Treatment of
Malaria, 3rd edition. Geneva, Switzerland: WHO. Available at:
http://www.who.int/malaria/publications/atoz/9789241549127/
en/. Accessed February 14, 2017.
13. Msellem MI, Ma˚rtensson A, Rotllant G, Bhattarai A, Stro¨mberg J,
Kahigwa E, Garcia M, Petzold M, Olumese P, Ali A, 2009. In-
fluence of rapid malaria diagnostic tests on treatment and
health outcome in fever patients, Zanzibar—a crossover vali-
dation study. PLoS Med 6: e1000070.
14. Shillcutt S, Morel C, Goodman C, Coleman P, Bell D, Whitty CJ,
Mills A, 2008. Cost-effectiveness of malaria diagnostic meth-
ods inSub-SaharanAfrica in aneraof combination therapy.Bull
World Health Organ 86: 101–110.
15. Yukich J, D’Acremont V, Kahama J, Swai N, Lengeler C, 2010.
Cost savings with rapid diagnostic tests for malaria in low-
transmission areas: evidence from Dar es Salaam, Tanzania.
Am J Trop Med Hyg 83: 61–68.
16. Dalinjong PA, Welaga P, Akazili J, Kwarteng A, Bangha M, Oduro
A, Sankoh O, Goudge J, 2017. The association between health
insurance status and utilization of health services in rural
northern Ghana: evidence from the introduction of the national
health insurance scheme. J Health Popul Nutr 36: 42.
17. Danquah DA, Buabeng KO, Asante KP, Mahama E, Bart-Plange
C, Owusu-Dabo E, 2016. Malaria case detection using rapid
diagnostic test at the community level in Ghana: consumer
perception and practitioners’ experiences.Malar J 15: 34.
18. MbonyeAK,NdyomugyenyiR, TurindeA,MagnussenP,ClarkeS,
ChandlerC, 2010. The feasibility of introducing rapiddiagnostic
tests for malaria in drug shops in Uganda.Malar J 9: 367.
19. Reda H, 2012. Improving Efficiency, Access to and Quality of the
Rural Health ExtensionProgramme in Tigray, Ethiopia: theCase
of Malaria Diagnosis and Treatment. Medical Dissertations,
New Series, Umea˚ University, Sweden.
20. Thiam S, Thwing J, Diallo I, Fall FB, Diouf MB, Perry R, Ndiop M,
DioufML,CisseMM,DiawMM, 2012. Scale-up of home-based
management of malaria based on rapid diagnostic tests and
artemisinin-based combination therapy in a resource-poor
country: results in Senegal.Malar J 11: 334.
21. Mayxay M, Newton PN, Yeung S, Pongvongsa T, Phompida S,
Phetsouvanh R, White NJ, 2004. An assessment of the use of
malaria rapid tests by village health volunteers in rural Laos.
Trop Med Int Health 9: 325–329.
22. D’Acremont V, Lengeler C, Mshinda H, Mtasiwa D, Tanner M,
Genton B, 2009. Time to move from presumptive malaria
treatment to laboratory-confirmed diagnosis and treatment in
African children with fever. PLoS Med 6: e252.
23. Owusu-Agyei S, ErnestA,NetteyO,ZandohC,SulemanaA,Adda
R, Amenga-Etego S, Mbacke C, 2012. Demographic patterns
and trends in central Ghana: baseline indicators from the Kin-
tampo health and demographic surveillance system. Glob
Health Action 5: 19033.
24. Dery DB, Brown C, Asante KP, Adams M, Dosoo D, Amenga-
Etego S, Wilson M, Chandramohan D, Greenwood B, Owusu-
Agyei S, 2010.Patterns andseasonality ofmalaria transmission
in the forest-savannah transitional zones of Ghana. Malar J 9:
314.
25. Owusu-Agyei S et al., 2009. Epidemiology ofmalaria in the forest-
savanna transitional zone of Ghana.Malar J 8: 220.
26. Ministry of Health, 2009. Guidelines for Case Management of
Malaria in Ghana, 2nd edition. Accra, Ghana:Ministry of Health.
27. KwartengA,AsanteKP,Abokyi L,GyaaseS, Febir LG,MahamaE,
Konadu DG, Tawiah T, Adu-Gyasi D, Dosoo D, 2015. Provider
compliance to artemisinin-based combination therapy at pri-
mary health care facilities in the middle belt of Ghana. Malar J
14: 361.
28. Thiam S, Thior M, Faye B, Ndiop M, Diouf ML, Diouf MB, Diallo I,
Fall FB, Ndiaye JL, Albertini A, 2011. Major reduction in anti-
malarial drug consumption in Senegal after nation-wide in-
troduction of malaria rapid diagnostic tests. PLoS One 6:
e18419.
29. Elmardi KA, Malik EM, Abdelgadir T, Ali SH, Elsyed AH, Mudather
MA, Elhassan AH, Adam I, 2009. Feasibility and acceptability of
home-based management of malaria strategy adapted to
Sudan’s conditions using artemisinin-based combination
therapy and rapid diagnostic test.Malar J 8: 39.
TEST-BASED MANAGEMENT OF MALARIA AT LICENSED CHEMICAL SHOPS 273
30. Yeboah-Antwi K, Pilingana P, Macleod WB, Semrau K, Siazeele
K, Kalesha P, Hamainza B, Seidenberg P, Mazimba A, Sabin L,
2010. Community case management of fever due to malaria
and pneumonia in children under five in Zambia: a cluster ran-
domized controlled trial. PLoS Med 7: 1139.
31. Yasuoka J, Poudel KC, Poudel-Tandukar K, Nguon C, Ly P,
Socheat D, Jimba M, 2010. Assessing the quality of service of
village malaria workers to strengthen community-based
malaria control in Cambodia.Malar J 9: 109.
32. Wasunna B, Zurovac D, Goodman CA, Snow RW, 2008. Why
don’t health workers prescribe ACT? A qualitative study of
factors affecting the prescription of artemether-lumefantrine.
Malar J 7: 29.
33. Chandler CI, JonesC, BonifaceG, JumaK, ReyburnH,Whitty CJ,
2008. Guidelines and mindlines: why do clinical staff over-
diagnosemalaria in Tanzania?Aqualitative study.Malar J 7:53.
34. Mockenhaupt FP et al., 2004. Manifestation and outcome of se-
vere malaria in children in northern Ghana. Am J Trop Med Hyg
71: 167–172.
35. Lubell Y et al., 2011. Likely health outcomes for untreated acute
febrile illness in the tropics in decision and economic models; a
Delphi survey. PLoS One 6: e17439.
36. AroraG, Sajid A, Kalia VC, eds, 2017.DrugResistance in Bacteria,
Fungi, Malaria, and Cancer. Cham: Springer International
Publishing, 429–447.
37. White NJ, Olliaro PL, 1996. Strategies for the prevention of anti-
malarial drug resistance: rationale for combination chemo-
therapy for malaria. Parasitol Today 12: 399–401.
38. World Health Organization, 2001. WHO Global Strategy for
Containment of Antimicrobial Resistance. Geneva, Switzer-
land: WHO. Available at: http://www.who.int/drugresistance/
WHO_Global_Strategy_English.pdf. Accessed March 10,
2017.
39. Ashley EA et al.; Tracking Resistance to Artemisinin Collabora-
tion (TRAC), 2014. Spread of artemisinin resistance in Plas-
modium falciparummalaria. N Engl J Med 371: 411–423.
40. World Health Organization, 2014. Emergence and Spread of
Artemisinin Resistance Calls for Intensified Efforts to Withdraw
Oral Artemisinin-BasedMonotherapy from theMarket. Geneva,
Switzerland: WHO. Available at: http://www.who.int/malaria/.../
atoz/oral-artemisinin-based-monotherapies-1may2014.pdf.
Accessed March 10, 2017.
41. Keri L, Kaye D, Sibylle K, 2010. Referral practices and perceived
barriers to timely obstetric care among Ugandan traditional
birth attendants (TBA). Afr Health Sci 10: 75.
42. Mbonye AK, Buregyeya E, Rutebemberwa E, Clarke SE, Lal S,
Hansen KS, Magnussen P, LaRussa P, 2017. Referral of chil-
dren seeking care at private health facilities in Uganda.Malar J
16: 76.
43. Thomson A, Khogali M, de Smet M, Reid T, Mukhtar A, Peterson
S, von Schreeb J, 2011. Low referral completion of rapid
diagnostic test-negative patients in community-based treat-
ment of malaria in Sierra Leone.Malar J 10: 94.
44. Oshikoya K, Ojo O, 2008. Medication errors in paediatric out-
patient prescriptions of a teaching hospital in Nigeria. Nig Q J
Hosp Med 17: 74–78.
45. Larson CP, Sauve´ L, Senkungu JK, Arifeen SE, Brant R, 2015.
Development and validation of weight, height and age bands to
guide the prescription of fixed-dose dispersible tablet formu-
lations. J Pediatr Pharmacol Ther 20: 24–32.
46. Hansen KS, Pedrazzoli D, Mbonye A, Clarke S, Cundill B,
Magnussen P, Yeung S, 2012. Willingness-to-pay for a rapid
malaria diagnostic test and artemisinin-based combination
therapy from private drug shops in Mukono District, Uganda.
Health Policy Plan 28: 185–196.
47. Lebetkin E, Orr T, Dzasi K, Keyes E, Shelus V,Mensah S, Nagai H,
Stanback J, 2014. Injectable contraceptive sales at licensed
chemical seller shops in Ghana: access and reported use in
rural and periurban communities. Int Perspect Sex Reprod
Health 40: 21–27.
48. World Health Organization, 2007. Task Shifting: Rational Re-
distribution of Tasks among Health Workforce Teams: Global
Recommendations and Guidelines. Geneva, Switzerland:
WHO. Available at: http://www.who.int/healthsystems/TTR-
TaskShifting.pdf. Accessed June 20, 2018.
49. AnkomahA, AdebayoSB, Arogundade ED, Anyanti J, Nwokolo E,
Inyang U, Ipadeola OB, Meremiku M, 2014. The effect of mass
media campaign on the use of insecticide-treated bed nets
amongpregnantwomen inNigeria.MalarResTreat 2014Article
ID 694863, 7 pages, 2014. https://doi.org/10.1155/2014/
694863.
50. Baiden F, Malm K, Bart-Plange C, Hodgson A, Chandramohan D,
Webster J, Owusu-Agyei S, 2014. Shifting from presumptive to
test-based management of malaria-technical basis and impli-
cations formalaria control inGhana.GhanaMed J 48: 112–122.
51. Bastiaens GJ, Bousema T, Leslie T, 2014. Scale-up of malaria
rapid diagnostic tests and artemisinin-based combination
therapy: challenges and perspectives in Sub-Saharan Africa.
PLoS Med 11: e1001590.
52. BoaduNY,Amuasi J, AnsongD,Einsiedel E,MenonD,YanowSK,
2016. Challenges with implementing malaria rapid diagnostic
tests at primary care facilities in aGhanaiandistrict: a qualitative
study.Malar J 15: 126.
53. Sridhar D, 2010. Seven challenges in international development
assistance for health and ways forward. J Law Med Ethics 38:
459–469.
54. Olcay M, Laing R, 2004. Pharmaceutical Tariffs: What is Their Effect
on Prices, Protection of Local Industry and Revenue Generation?
Geneva, Switzerland: WHO. Available at: http://www.who.int/
intellectualproperty/studies/TariffsOnEssentialMedicines.pdf.
Accessed March 20, 2018.
274 KWARTENG AND OTHERS
